Bioelectronics Corp (BIEL)

[ddls]

When BioElectronics miniaturized their PEMF they also unknowingly miniaturized their stock valuation in the process.

The device is just barely powerful enough to speed the healing of a pimple. Thus, what we have here today, .0006, which is still way overvalued as the current EPS with losses of (.00005).

Q4 and full year results are April 1, and expect 2018 sales of only 1.1M to 1.2M tops. This will be a decline from 2017's 1.76M of 35%